IP Library › Patent Application 17214377
Patent Application
App. No. 17/214,377

METHOD OF TREATING ALZHEIMER'S DISEASE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/214,377
Abstract

A method of treating or preventing Alzheimer's disease comprising administering a pharmaceutical composition comprising 64 Zn e or a salt thereof, at a therapeutically effective or a prophylactically effective dose for treating or preventing the disease.

Claims (12)

1 . 1. A method of treating Alzheimer's disease in a subject in need thereof comprising administering to said subject a therapeutically effective amount of a composition comprising Zn, wherein the composition comprises a 64 Zn e compound or a salt thereof, wherein the 64 Zn e compound or a salt thereof is at least 80% 64 Zn e .

2 . The method of claim 1 , wherein said 64 Zn e compound or a salt thereof is at least 95% 64 Zn e .

3 . The method of claim 1 , wherein said 64 Zn e compound or a salt thereof and said 64 Zn e compound is at least 99% 64 Zn e .

4 . The method of claim 1 , wherein the 64 Zn e is in a form of salt selected from the group consisting of aspartate, sulfate, and citrate.

5 . The method of claim 1 , wherein the composition is administered by injection.

6 . The method of claim 1 , wherein the composition is administered orally.

7 . A method of delaying the onset of Alzheimer's disease comprising administering to a subject in need thereof a prophylactically effective amount of a composition comprising Zn, wherein the composition comprises a 64 Zn e compound or a salt thereof, wherein the 64 Zn e compound or a salt thereof is at least 80% 64 Zn e .

8 . The method of claim 7 , wherein said 64 Zn e compound or a salt thereof is at least 95% 64 Zn e .

9 . The method of claim 7 , wherein said 64 Zn e compound or a salt thereof and said 64Zn e compound is at least 99% 64 Zn e .

10 . The method of claim 7 , wherein the 64 Zn e is in a form of salt selected from the group consisting of aspartate, sulfate, and citrate.

11 . The method of claim 7 , wherein the composition is administered by injection.

12 . The method of claim 7 , wherein the composition is administered orally.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2024
From: NOVAK, PETER; TEMNIKOV, MAXIM
To: VECTOR VITALE IP LLC
Reel/Frame 067796/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2023
From: VECTOR VITALE IP LLC
To: NOMAX THERAPEUTICS, INC.
Reel/Frame 065038/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2021
From: NOVAK, PETER; TEMNIKOV, MAXIM
To: VECTOR VITALE IP LLC
Reel/Frame 055921/0489 →